These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809 [TBL] [Abstract][Full Text] [Related]
4. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Levine RJ; Qian C; Maynard SE; Yu KF; Epstein FH; Karumanchi SA Am J Obstet Gynecol; 2006 Apr; 194(4):1034-41. PubMed ID: 16580293 [TBL] [Abstract][Full Text] [Related]
5. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia. Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881 [TBL] [Abstract][Full Text] [Related]
6. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia. Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884 [TBL] [Abstract][Full Text] [Related]
8. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077 [TBL] [Abstract][Full Text] [Related]
9. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Bdolah Y; Elchalal U; Natanson-Yaron S; Yechiam H; Bdolah-Abram T; Greenfield C; Goldman-Wohl D; Milwidsky A; Rana S; Karumanchi SA; Yagel S; Hochner-Celnikier D Hypertens Pregnancy; 2014 May; 33(2):250-9. PubMed ID: 24304210 [TBL] [Abstract][Full Text] [Related]
11. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia. Bian Z; Shixia C; Duan T PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026 [TBL] [Abstract][Full Text] [Related]
12. [THE ROLE OF ANGIOGENIC FACTORS IN THE DIAGNOSTICS OF PREGNANCY COMPLICATED WITH PREECLAMPSIA]. Tagiyeva I; Aliyeva S; Bagirova S; Shamsadinskaya N; Agaeva K Georgian Med News; 2017; (268-269):35-38. PubMed ID: 28820409 [TBL] [Abstract][Full Text] [Related]
13. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519 [TBL] [Abstract][Full Text] [Related]
14. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749 [TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors for the prediction of preeclampsia in high-risk women. Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405 [TBL] [Abstract][Full Text] [Related]
16. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808 [TBL] [Abstract][Full Text] [Related]
17. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia. Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883 [TBL] [Abstract][Full Text] [Related]
19. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Petrozella L; Mahendroo M; Timmons B; Roberts S; McIntire D; Alexander JM Am J Obstet Gynecol; 2012 Aug; 207(2):140.e20-6. PubMed ID: 22840727 [TBL] [Abstract][Full Text] [Related]
20. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]